Steve E. Krognes sold $608K of Denali Therapeutics (DNLI)

Executed Dec 31 2024, disclosed Jan 3 2025, 3 days later.

Value, as filed

$608K

30,000 sh × $20.25

Executed

Dec 31 2024

the trade date, as filed

Disclosed

Jan 3 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SK Steve E. Krognes Director profile →

Steve E. Krognes (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Denali Therapeutics Inc. (DNLI). The largest single filing was $1.2M of GH (9,294 sh × $132.51, as filed), executed Jun 4.

The name

DNLI Denali Therapeutics Inc. DNLI · Healthcare · 12 filings in 24 months ticker →

Healthcare · Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Steve E. Krognes in DNLI

DNLISALE Denali Therapeutics Inc. $871K
30,000 sh × $29.03
Exec Sep 30 2024
Filed Oct 2 2024 · 5:30 PM ET